We're not in the business of HIV/AIDS drugs, but we're in the business of multi-drug-resistant tuberculosis, which is often fatal to people who have AIDS. We have negotiated with the South African government. We have negotiated with the Indian government. We have negotiated with the Chinese government. We've also negotiated with Russia.
What we've done is we've created, through technology transfer, the ability of all four of those countries to produce two very old compounds that have been off patent for years, but nobody wanted to invest in developing them. We've provided the technology, the tech transfer, the training, and $150 million in funding to increase the supply of these drugs in the third world. That's what we've done.